Roche

Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda
Pharmaforum
Tue, 01/11/22 - 11:28 am
Merck
Roche
Keytruda
clinical trials
non-small cell lung cancer
Tecentriq
Roche, Siemens at-home tests get EUAs as US faces COVID-19 testing shortage
Medtech Dive
Wed, 01/5/22 - 10:40 am
Roche
Siemens Healthineers
Medtech
diagnostics
COVID-19
COVID-19 testing
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Medtech developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:24 am
Medtech
devices
COVID-19
diagnostics
Quidel
Ortho Clinical Diagnostics
M&A
FDA
Roche
Tide Laboratories
Meridian Bioscience
Applied DNA Science
Siemens Healthineers
2022 forecast: How marketers must learn from Biogen's marketing struggles with Aduhelm
Fierce Pharma
Mon, 12/27/21 - 11:10 am
Biogen
Aduhelm
pharma marketing
Alzheimer's disease
Roche
Eli Lilly
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset
Fierce Biotech
Mon, 12/20/21 - 11:32 pm
Roche
Genentech
Lineage Cell Therapeutics
cell therapy
dry age-related macular degeneration
Go or no go? Roche’s fresh start for a new year
EP Vantage
Mon, 12/20/21 - 10:59 am
FDA
Roche
Novartis
Pfizer
AstraZeneca
Cibinqo
Lynparza
Tezspire
Vyvgart
faricimab
ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma
Endpoints
Tue, 12/14/21 - 11:12 am
ASH2021
Roche
antibody-drug conjugate
Polivy
Genentech
blood cancers
ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio
Endpoints
Sun, 12/12/21 - 11:31 pm
ASH2021
Roche
Genentech
bispecific antibodies
blood cancer
mosunetuzumab
Roche builds case for TIGIT combo in untreated lung cancer
Pharmaforum
Fri, 12/10/21 - 10:50 am
Roche
anti-TIGIT
tiragolumab
Tecentriq
lung cancer
Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU
Biopharma Reporter
Tue, 12/7/21 - 11:04 am
Roche
Actemra
RoActemra
COVID-19
Europe
Roche Signs Machine-Learning Neuroscience Deal With Recursion
Bloomberg
Tue, 12/7/21 - 10:53 am
Roche
Genentech
artificial intelligence
machine learnings
Recursion Pharmaceuticals
cancer
Neuroscience
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
Motley Fool
Sun, 11/28/21 - 11:03 pm
Roche
Biogen
Alzheimer's disease
Aduhelm
gantenerumab
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
Motley Fool
Sat, 11/20/21 - 12:01 pm
Regeneron
Roche
COVID-19
antibodies
Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: report
Fierce Pharma
Thu, 11/18/21 - 10:50 am
Novartis
Roche
M&A
Alnylam
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
Fierce Biotech
Wed, 11/17/21 - 10:28 am
Roche
Merck
Pfizer
Atea Pharmaceuticals
COVID-19
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
Thu, 11/11/21 - 10:59 am
AC Immune
Roche
anti-tau antibodies
Alzheimer's disease
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Novartis
M&A
Roche
Sandoz
Aurinia Pharmaceuticals
Alnylam
Exelixis
Incyte
Eisai
Genmab
Novartis to sell its Roche stake for $20.7 billion
Axios
Thu, 11/4/21 - 10:54 am
Novartis
Roche
Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer
Xtalks
Wed, 10/27/21 - 10:58 am
Genentech
Roche
ocular implant delivery
macular degeneration
FDA
wet age-related macular degeneration

Pages